Author

Amro Elshoury

Institution: Indiana Hemophilia and Thrombosis Center

Observed institutions: Northwestern University, Roswell Park Comprehensive Cancer Center, Buffalo Society of Natural Sciences, Children's Hospital of Los Angeles, Cancer Consortium, Indiana Hemophilia and Thrombosis Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Albany Medical College, University at Buffalo, State University of New York, Albany Medical Center Hospital

OpenAlex ID: A5060296758

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

2022 · John A. Thompson, Bryan J. Schneider, et al. · Journal of the National Comprehensive Cancer Network · 426

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

2021 · Michael A. Thompson, Jeffrey P. Henderson, et al. · JAMA Oncology · 192

PDF

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

2021 · Michael B Streiff, Bjorn Holmstrom, et al. · PubMed · 149

Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

2022 · Aaron T. Gerds, Jason Gotlib, et al. · Journal of the National Comprehensive Cancer Network · 137

PDF

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

2022 · Julie Fu, Sonya A. Reid, et al. · JAMA Network Open · 66

PDF

Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution

2017 · Hisham Abdel-Azim, Amro Elshoury, et al. · Transplantation and Cellular Therapy · 65

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

2020 · Aaron T. Gerds, Jason Gotlib, et al. · Journal of the National Comprehensive Cancer Network · 55

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54

PDF

Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19

2021 · Andrew L. Schmidt, Matthew D. Tucker, et al. · JAMA Network Open · 38

PDF

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

2020 · Maheen Abidi, David M. Aboulafia, et al. · Cancer Cell · 31

PDF

The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19

2021 · Ang Li, Nicole M. Kuderer, et al. · Journal of Thrombosis and Haemostasis · 30

PDF

Advancing treatment of acute myeloid leukemia: the future of FLT3 inhibitors

2019 · Amro Elshoury, Amanda Przespolewski, et al. · Expert Review of Anticancer Therapy · 28

Update on Guidelines for the Prevention of Cancer-Associated Thrombosis

2022 · Amro Elshoury, Jordan K. Schaefer, et al. · Journal of the National Comprehensive Cancer Network · 26

Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty

2015 · Amro Elshoury, Maha Khedr, et al. · Arthroplasty Today · 18

PDF

How to Choose An Appropriate Anticoagulant for Cancer-Associated Thrombosis.

2021 · Jordan K Schaefer, Amro Elshoury, et al. · PubMed · 17

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

2022 · Jessica E. Hawley, Tianyi Sun, et al. · JAMA Network Open · 10

PDF

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

2020 · Ang Li, Nicole M. Kuderer, et al. · Blood · 8

ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

2023 · Hassan Awada, Manasa Bhatta, et al. · Leukemia · 6

Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival

2020 · Almuth M.A. Merz, Maximilian Merz, et al. · Transplantation and Cellular Therapy · 6

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy

2021 · Amanda Przespolewski, Monica R. Muppidi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5

MPN-274 Avapritinib in Patients With Advanced Systemic Mastocytosis (AdvSM): Efficacy and Safety Analysis From the Phase 2 PATHFINDER Study With 3-Year Follow-up

2024 · Andreas Reiter, Jason Gotlib, et al. · Clinical Lymphoma Myeloma & Leukemia · 4

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

2020 · Amanda Przespolewski, Elizabeth A. Griffiths, et al. · Blood · 3

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study

2026 · Jason Gotlib, Andreas Reiter, et al. · Blood Advances · 2

PDF

Short-Term Storage of Mobilized Peripheral Blood Stem Cells in a Closed System Changes the Microenvironment and May Affect the Quantity of CD34+ and CD34+CD38-CD45RA-CD90+ Cells

2022 · Amro Elshoury, Orla Maguire, et al. · Transplantation and Cellular Therapy · 2

ASXL1 Mutation Is a Novel Risk Factor for Bleeding in Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN)

2021 · Amro Elshoury, Han Yu, et al. · Blood · 2

Works count: 34

Citation count: 1,384

H-index: 15

I10-index: 16